The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle
- Authors: Kirillova VV1,2,3, Sokolova LA1,3, Meshchaninov VN1,2, Pershanova VI3
-
Affiliations:
- Ural state medical University
- Institute for medical cell technologies
- Medical Center Ural, Department of the early diagnostic and treatment of chronic heart failure
- Issue: Vol 90, No 9 (2018)
- Pages: 68-72
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32992
- DOI: https://doi.org/10.26442/terarkh201890968-72
- ID: 32992
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
V V Kirillova
Ural state medical University; Institute for medical cell technologies; Medical Center Ural, Department of the early diagnostic and treatment of chronic heart failure
Email: venova@list.ru
к.м.н., с.н.с. лаб. антивозрастных технологий ГАУЗ СО «Институт медицинских клеточных технологий»; ассистент каф. биохимии ФГБОУ ВО УГМУ Минздрава РФ; зав. отд. ранней диагностики и лечения хронической сердечной недостаточности ООО Клиника «Уральская», ORCID 0000-0001-6254-0756 Yekaterinburg, Russia
L A Sokolova
Ural state medical University; Medical Center Ural, Department of the early diagnostic and treatment of chronic heart failureд.м.н., проф., зав. каф. скорой медицинской помощи ФГБОУ ВО УГМУ Минздрава РФ; директор ООО Клиника «Уральская» Yekaterinburg, Russia
V N Meshchaninov
Ural state medical University; Institute for medical cell technologiesд.м.н., проф., г.н.с., зав. лаб. антивозрастных технологий ГАУЗ СО «Институт медицинских клеточных технологий»; зав. каф. биохимии ФГБОУ ВО УГМУ Минздрава РФ Yekaterinburg, Russia
V I Pershanova
Medical Center Ural, Department of the early diagnostic and treatment of chronic heart failureврач клинико-диагностической лаборатории ООО Клиника «Уральская» Yekaterinburg, Russia
References
- Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;8(136):7-13 doi:10.15829/ 1560-4071-2016-8-7-13
- Paulus W.J, Tschope C, Sanderson J.E, Rusconi C, Flachskampf F.A, Rademakers F.E, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539-50. doi: 10.1093/eurheartj/ehm037
- Caballero L, Kou S, Dulgheru R, Gonjilashvili N, Athanassopoulos G.D, Barone D, et al. Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Heart J Cardiovasc Imaging. 2015;16:1031-41. doi: 10.1093/ehjci/jev083
- Lang M, Badano L.P, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233-70. doi: 10.1016/j.echo.2014.10.003
- Maisel A, Krishnaswamy P, Nowak R, Mc Cord J, Hollander J.E, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-7. doi: 10.1056/NEJMoa020233
- Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-12. doi: 10.1172/JCI115146
- Hunt P.J, Yandle T.G, Nicholls M.G Richards A.M, Espiner E.A. The amino - terminal portion of pro - brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun. 1995;214:1175-83. doi: 10.1006/bbrc.1995.2410
- Ponikowski P, Voors A.A, Anker S.D, Bueno H, Cleland J.G, Coats A.J, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart J. 2016;37(27):2129-200. doi: 10.1093/eurheartj/ehw128
- Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Арутюнов Г.П., Беграмбекова Ю.Л., Беленков Ю.Н. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Сердечная Недостаточность. 2017;18(1):3-40 doi: 10.18087/rhfj.2017.1.2346
- Maisel A, Mueller C, Adams K, Anker S.D, Aspromonte N, Cleland J.G.F, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824-39. doi: 10.1016/j.ejheart.2008.07.014
- Wilson Tang W.H, Girod J.P, Lee M.J, Starling R.C, Young J.B, Van Lente F. Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic. Heart Failure Circulation. 2003;108:2964-6. doi: 10.1161/01.CIR.0000106903. 98196.B6
- Santosa Y.P, Tjandrawati A, Noormartany, Erwinanto, Yahya A.F, Martanto E, et al. Comparison of Pro B-natriuretic Peptide in Hypertensive Patients with and without Diastolic Dysfunction. Acta Med Indones. 2008;40(1):19-23.
- Knebel F, Eddicks S, Schimke I, Bierbaum M, Schattke S, Beling M, et al. Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure. Cardiobvasc Ultrasoud. 2008;6:45. doi: 10.1186/1476-7120-6-45
- Maisel A, Koon J, Krishnaswamy P, Kazenegra R, Clopton P, Gardetto N, et al. Utility of B-natriuretic peptide as a rapid, point - of - care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141(3):367-74. doi:10.1067/ mhj.2001.113215
- Nagueh S.F, Smiseth O.A, Appleton C.P, Byrd B.F 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321-60. doi: 10.1093/ehjci/jew082
- Ommen S.R, Nishimura R.A, Appleton C.P, Miller F.A, Oh J.K, Redfield M.M, et al. Clinical utility of doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures. A comparative simultaneous doppler - catheterization Study. Circulation. 2000;102:1788-94.
- Hung T.C, Wang K.T, Yun C.H, Kuo J.Y, Hou C.J, Liu C.Y, et al. Value of serum N-terminal B-type natriuretic peptide in asymptomatic structural heart disease in Taiwanese population: Comparisons with current ESC Guidelines. Int J Cardiol. 2017;231:195-200. doi: 10.1016/j.ijcard.2016.12.180
- Подзолков В.И., Тарзиманова А.И., Лория И.Ж. Изменение уровня натрийуретических пептидов у пациентов с фибрилляцией предсердий при лечении антиаритмическими препаратами. Рациональная фармакотерапия в кардиологии. 2015;11(4):365-70
- Ellinor P.T, Low A.F, Patton K.K, et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in atrial fibrillation. J Am Coll Cardiol. 2005;45:82-6. doi: 10.1016/j.jacc.2004.09.045